e-learning
resources
Munich 2014
Wednesday, 10.09.2014
The more in-depth classification of lung cancer: relevance for patients and science
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung cancer classification and characterisation in daily practice of thoracic oncology
E. Quoix (Strasbourg, France)
Source:
International Congress 2014 – The more in-depth classification of lung cancer: relevance for patients and science
Session:
The more in-depth classification of lung cancer: relevance for patients and science
Session type:
Hot topics
Number:
4817
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Quoix (Strasbourg, France). Lung cancer classification and characterisation in daily practice of thoracic oncology. International Congress 2014 – The more in-depth classification of lung cancer: relevance for patients and science
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Synchronous primary lung cancers;a clinical challenge in modern thoracic oncology
Source: International Congress 2018 – Thoracic surgery, pleural effusions and other general thoracic surgery
Year: 2018
Single-institution experience of surgical management of metastasises of colorectal cancer in lungs: Lessons learned
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Does IASLC/ATS/ERS classification of lung adenocarcinoma impacts prognosis?
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Single-institution experience of the combined operations in management of lung cancer: Lessons learned
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Multidisciplinary management of lung cancer in a university teaching hospital in Algiers
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Improving survival for NSCLC patients in the national lung cancer audit
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Reducing the rate of emergency presentation in lung cancer
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Diagnosing lung cancer: Choosing the best for your patient
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Reduced perioperative mortality after centralization of lung cancer surgery
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
A survey of outcome of CT guided lung biopsies in a tertiary centre
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Validating an EBUS service provided by a group of operators with different levels of experience
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
Treatment of advanced non-small cell lung cancer with trofosfamide
Source: Annual Congress 2013 –Advances in the therapy of lung cancer
Year: 2013
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
Completion pneumonectomy for lung cancer relapse after surgery- What is a real benefit?
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Added value of EUS-B to EBUS for lung cancer staging
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
Pathology meets clinic: translating lung cancer pathology into personalised care
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017
Defining a standard set of patient-centered outcomes for patients with lung cancer
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Metronomic chemotherapy in human lung cancer: Mathematical modeling for an optimal schedule
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
Implications of new lung adenocarcinoma classification for oncologists
Source: Annual Congress 2009 - The new ERS/ATS/IASLC classification of lung adenocarcinoma: practice update
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept